Exact Mass: 447.23692380000006
Exact Mass Matches: 447.23692380000006
Found 194 metabolites which its exact mass value is equals to given mass value 447.23692380000006
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-(2H-Benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
Thr Lys Ala Glu
Ala Glu Lys Thr
Ala Glu Thr Lys
Ala Lys Glu Thr
Ala Lys Thr Glu
Ala Arg Thr Thr
Ala Thr Glu Lys
Ala Thr Lys Glu
Ala Thr Arg Thr
Ala Thr Thr Arg
Asp Lys Ser Val
Asp Lys Val Ser
Asp Ser Lys Val
Asp Ser Val Lys
Asp Val Lys Ser
Asp Val Ser Lys
Glu Ala Lys Thr
Glu Ala Thr Lys
Glu Lys Ala Thr
Glu Lys Thr Ala
Glu Thr Ala Lys
Glu Thr Lys Ala
Ile Asn Thr Thr
Ile Gln Ser Thr
Ile Gln Thr Ser
Ile Ser Gln Thr
Ile Ser Thr Gln
Ile Thr Asn Thr
Ile Thr Gln Ser
Ile Thr Ser Gln
Ile Thr Thr Asn
Lys Ala Glu Thr
Lys Ala Thr Glu
Lys Asp Ser Val
Lys Asp Val Ser
Lys Glu Ala Thr
Lys Glu Thr Ala
Lys Ser Asp Val
Lys Ser Val Asp
Lys Thr Ala Glu
Lys Thr Glu Ala
Lys Val Asp Ser
Lys Val Ser Asp
Leu Asn Thr Thr
Leu Gln Ser Thr
Leu Gln Thr Ser
Leu Ser Gln Thr
Leu Ser Thr Gln
Leu Thr Asn Thr
Leu Thr Gln Ser
Leu Thr Ser Gln
Leu Thr Thr Asn
Asn Ile Thr Thr
Asn Leu Thr Thr
Asn Thr Ile Thr
Asn Thr Leu Thr
Asn Thr Thr Ile
Asn Thr Thr Leu
Gln Ile Ser Thr
Gln Ile Thr Ser
Gln Leu Ser Thr
Gln Leu Thr Ser
Gln Ser Ile Thr
Gln Ser Leu Thr
Gln Ser Thr Ile
Gln Ser Thr Leu
Gln Thr Ile Ser
Gln Thr Leu Ser
Gln Thr Ser Ile
Gln Thr Ser Leu
Gln Thr Thr Val
Gln Thr Val Thr
Gln Val Thr Thr
Arg Ala Thr Thr
Arg Ser Ser Val
Arg Ser Val Ser
Arg Thr Ala Thr
Arg Thr Thr Ala
Arg Val Ser Ser
Ser Asp Lys Val
Ser Asp Val Lys
Ser Ile Gln Thr
Ser Ile Thr Gln
Ser Lys Asp Val
Ser Lys Val Asp
Ser Leu Gln Thr
Ser Leu Thr Gln
Ser Gln Ile Thr
Ser Gln Leu Thr
Ser Gln Thr Ile
Ser Gln Thr Leu
Ser Arg Ser Val
Ser Arg Val Ser
Ser Ser Arg Val
Ser Ser Val Arg
Ser Thr Ile Gln
Ser Thr Leu Gln
Ser Thr Gln Ile
Ser Thr Gln Leu
Ser Val Asp Lys
Ser Val Lys Asp
Ser Val Arg Ser
Ser Val Ser Arg
Thr Ala Glu Lys
Thr Ala Lys Glu
Thr Ala Arg Thr
Thr Ala Thr Arg
Thr Glu Ala Lys
Thr Glu Lys Ala
Thr Ile Asn Thr
Thr Ile Gln Ser
Thr Ile Ser Gln
Thr Ile Thr Asn
Thr Lys Glu Ala
Thr Leu Asn Thr
Thr Leu Gln Ser
Thr Leu Ser Gln
Thr Leu Thr Asn
Thr Asn Ile Thr
Thr Asn Leu Thr
Thr Asn Thr Ile
Thr Asn Thr Leu
Thr Gln Ile Ser
Thr Gln Leu Ser
Thr Gln Ser Ile
Thr Gln Ser Leu
Thr Gln Thr Val
Thr Gln Val Thr
Thr Arg Ala Thr
Thr Arg Thr Ala
Thr Ser Ile Gln
Thr Ser Leu Gln
Thr Ser Gln Ile
Thr Ser Gln Leu
Thr Thr Ala Arg
Thr Thr Ile Asn
Thr Thr Leu Asn
Thr Thr Asn Ile
Thr Thr Asn Leu
Thr Thr Gln Val
Thr Thr Arg Ala
Thr Thr Val Gln
Thr Val Gln Thr
Thr Val Thr Gln
Val Asp Lys Ser
Val Asp Ser Lys
Val Lys Asp Ser
Val Lys Ser Asp
Val Gln Thr Thr
Val Arg Ser Ser
Val Ser Asp Lys
Val Ser Lys Asp
Val Ser Arg Ser
Val Ser Ser Arg
Val Thr Gln Thr
Val Thr Thr Gln
palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-[[(2S,3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2S,3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2R,3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2S,3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2R,3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2R,3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2S,3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
N-[[(2R,3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
C23H33N3O6 (447.23692380000006)
2-[(1R,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
2-[(1R,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
2-[(1S,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
2-[(1S,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
2-[(1R,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
2-[(1S,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
C23H33N3O6 (447.23692380000006)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C21H38NO7P (447.23857680000003)
(3r,3ar,6ar,10s,12s,15r)-3-benzyl-1,15-dihydroxy-4,5,10,12-tetramethyl-3h,3ah,6ah,9h,10h,12h,15h-cycloundeca[d]isoindole-6,11-dione
(3s,3ar,6s,6ar,14r,15as)-1,6-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-14-(methylsulfanyl)-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C25H37NO4S (447.24431620000007)
(3s,4r,7r,9s,10s,13s,14s,16r,19s,27s)-13-ethenyl-17,19-dihydroxy-7-methyl-2-oxa-18-azahexacyclo[19.2.2.1³,¹⁰.1¹⁶,¹⁹.0⁴,⁹.0¹⁴,²⁷]heptacosa-1(23),11,17,21,24-pentaen-15-one
1,6-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-14-(methylsulfanyl)-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
C25H37NO4S (447.24431620000007)